Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laura Faden Garabedian, Ph.D.

Concepts (108)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Comparative Effectiveness Research220146660.790 Why?
Insurance, Health4202023220.780 Why?
Diabetes Mellitus4202046610.740 Why?
Blood Glucose Self-Monitoring120192510.720 Why?
Telemedicine2201917820.540 Why?
Insurance Coverage2202016860.390 Why?
Insurance, Pharmaceutical Services320103320.360 Why?
Drug Approval520107800.360 Why?
Quality Assurance, Health Care1201823760.330 Why?
Health Care Reform1201612780.330 Why?
Patient Acceptance of Health Care2201927850.320 Why?
Quality of Health Care2201843810.310 Why?
Blood Glucose1201958750.290 Why?
Insurance, Health, Reimbursement220094200.280 Why?
Product Surveillance, Postmarketing220094540.280 Why?
Attitude of Health Personnel1201838890.270 Why?
Research Personnel120084470.270 Why?
Formularies as Topic32009910.250 Why?
Minority Groups120088130.240 Why?
Primary Health Care1201841150.240 Why?
Medical Savings Accounts12020240.230 Why?
Interviews as Topic2201826890.220 Why?
Insurance Carriers12020950.210 Why?
Drug Utilization Review120112620.210 Why?
Government Programs120112210.200 Why?
Cost Sharing220203940.200 Why?
Economic Competition120102280.190 Why?
Intrauterine Devices120191030.190 Why?
Patient Protection and Affordable Care Act2202010960.190 Why?
Deductibles and Coinsurance120202770.180 Why?
Eligibility Determination120203550.170 Why?
Off-Label Use120091670.170 Why?
New England120189640.160 Why?
Health Services120117030.160 Why?
Pharmacoepidemiology120082720.150 Why?
Internationality220089720.150 Why?
Drug Industry220109180.150 Why?
Patient Selection1200843470.150 Why?
Drug Design1201011660.150 Why?
Focus Groups1201811930.140 Why?
Risk Management120085900.140 Why?
Pharmaceutical Preparations220107620.130 Why?
Research Design1200855920.120 Why?
Drug Monitoring120088820.120 Why?
Program Evaluation1201126020.120 Why?
Insurance Claim Review120167280.120 Why?
Qualitative Research1201819880.110 Why?
Equipment Design1201936180.110 Why?
International Cooperation1200815910.100 Why?
Self Care120158330.100 Why?
Health Services Accessibility2200746830.100 Why?
Humans1920206446660.100 Why?
United States82020614320.100 Why?
Poverty1202023210.100 Why?
United States Food and Drug Administration4201015760.100 Why?
Developing Countries1201026510.090 Why?
Hypoglycemic Agents1202024130.090 Why?
Antipsychotic Agents1201129630.090 Why?
Quality Indicators, Health Care1201817940.090 Why?
Massachusetts2201986240.090 Why?
Drug Prescriptions1200715730.080 Why?
Regression Analysis1201468270.070 Why?
Prejudice120085890.070 Why?
Schizophrenia1201163970.060 Why?
Socioeconomic Factors1201677600.060 Why?
Immunotherapy1200530420.060 Why?
Time Factors32016420350.050 Why?
Patents as Topic120101470.050 Why?
Middle Aged420202091700.050 Why?
Data Collection1200833070.050 Why?
Pharmacopoeias as Topic12007160.050 Why?
Financing, Personal120203070.040 Why?
Antibodies, Monoclonal1200598000.040 Why?
European Union120081480.040 Why?
Continental Population Groups1200822180.040 Why?
Follow-Up Studies12019386390.040 Why?
Pharmacy and Therapeutics Committee1200690.040 Why?
Female620203609480.040 Why?
Clinical Trials as Topic2200878940.040 Why?
Male520203409400.040 Why?
France120075060.040 Why?
Government Agencies120061610.040 Why?
Cost-Benefit Analysis2201051150.040 Why?
Adolescent32020808870.040 Why?
Hybridomas120054470.040 Why?
State Medicine120061850.040 Why?
Chemistry, Pharmaceutical120053180.040 Why?
Japan1200813380.030 Why?
Marketing120062240.030 Why?
Biotechnology120053110.030 Why?
Government Regulation120085430.030 Why?
Safety1200812460.030 Why?
Retrospective Studies12019597640.030 Why?
Netherlands1200721950.030 Why?
Physicians1200837830.030 Why?
Medicare2200944660.030 Why?
Adult320202036580.030 Why?
Reimbursement Mechanisms120066540.030 Why?
Patient Participation1200713800.020 Why?
Aged120191552000.020 Why?
Anxiety1201931620.020 Why?
Evidence-Based Medicine1200937240.020 Why?
Longitudinal Studies12020126170.020 Why?
Young Adult22020524540.020 Why?
Health Care Costs1200730820.020 Why?
Child12020661740.010 Why?
Neoplasms12005178010.010 Why?
Animals120051699350.000 Why?
Garabedian's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (108)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.